News|Articles|October 6, 2026

3 Hematology Headlines You Missed in September 2026

Hematology in September 2026: ASH raises ferritin thresholds for iron deficiency, plus marstacimab in hemophilia and curative SCD care.

Hematology news in September 2026 included new diagnostic thresholds for iron deficiency, a closer look at the expanded approval of marstacimab in hemophilia A and B, and expert perspective on choosing between curative therapies in sickle cell disease.

Related to this article

October 6th, 2026

ACG Guideline Sets 18 Preventive Care Recommendations for Cirrhosis

Strong recommendations cover carvedilol or banding for varices, semiannual HCC surveillance, vaccines, and smoking cessation.

October 6th, 2026

RELIEVE-AD-PEDs: Dupilumab Sustains Adolescent Atopic Dermatitis Control at 1 Year

April Armstrong, MD, MPH, discusses 1-year RELIEVE-AD-PEDs data on rapid, sustained dupilumab disease control in adolescents with atopic dermatitis.

October 6th, 2026

Top Reason for Leaving HAE Attacks Untreated, Survey Finds

Physicians and patients cited perceived mild severity as the top reason for leaving HAE attacks untreated in a recent Adelphi survey.

October 5th, 2026

6 Nephrology Headlines You Missed in September 2026

Nephrology in September 2026: FDA approves finerenone for CKD in T1D and obinutuzumab for nephrotic syndrome, plus ORIGIN 3 IgAN data.

October 5th, 2026

5 Gastroenterology Headlines You Missed in September 2026

Gastroenterology in September 2026: SPY003 phase 2 data in UC, antifungal therapy in IBD, and EPI prevalence in chronic pancreatitis.

October 5th, 2026

EADV 2026: TNFα, OX40L Cluster at HS Draining Tunnels

Late-breaking EADV data show TNFα and OX40L localize near HS draining tunnels as Navigator Medicines advances its dual-targeting bispecific antibodies.